Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Nasal Spray for Sudden Sensorineural Hearing Loss and Sleep Quality
ChiCTR2400091397Phase 4Not yet recruiting
- Sponsor
- Liaocheng City People's Hospital
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in acute sensorineural hearing loss, sleep disorder, tinnitus and 2 more (2 arms), sponsored by Liaocheng City People's Hospital. Primary endpoints: Pure tone audiometry and LESQ Sleep Score report. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
acute sensorineural hearing losssleep disordertinnitusvertigo
Beyond the preview
Go deeper on ChiCTR2400091397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091397.